Effect of a Commercial Cosmetic Mouth Rinse on Plaque Re-growth

NCT ID: NCT01122862

Last Updated: 2013-09-09

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2

Total Enrollment

23 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-04-30

Study Completion Date

2010-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A clinical study to evaluate the effect of a commercial mouth rinse on plaque re-growth

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Subjects

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

tooth plaque

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

0.12% Chlorhexidine Mouthrinse

Commercially available 0.12% Chlorhexidine mouthrinse

Group Type ACTIVE_COMPARATOR

0.12% chlorhexidine mouthrinse

Intervention Type DRUG

commercially available 0.12% chlorhexidine mouthrinse

Cosmetic mouthrinse

Commercially available cosmetic mouthrinse

Group Type ACTIVE_COMPARATOR

Cosmetic mouthrinse

Intervention Type OTHER

Commerically available cosmetic mouthrinse

Sterile Water

Sterile Water

Group Type PLACEBO_COMPARATOR

Sterile water

Intervention Type OTHER

Sterile water

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

0.12% chlorhexidine mouthrinse

commercially available 0.12% chlorhexidine mouthrinse

Intervention Type DRUG

Cosmetic mouthrinse

Commerically available cosmetic mouthrinse

Intervention Type OTHER

Sterile water

Sterile water

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Good general and oral health
* At least 20 natural gradable teeth
* Mean plaque score (Turesky Modification of the Quigley Hein Index) of greater than or equal to 2.00 at the first baseline visit
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

GlaxoSmithKline

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

GSK Clinical Trials

Role: STUDY_DIRECTOR

GlaxoSmithKline

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

GSK Investigational Site

Fort Wayne, Indiana, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Z36420889

Identifier Type: -

Identifier Source: org_study_id